2012•Journal of Bengbu Medical CollegeRequires access

The effects of wenxinkeli on the arrhythmia of acute coronary syndrome and angiotensin II

Xie Chun-yi

Open publisher page 0 citations

Abstract

Objective:To observe the effects of wenxinkeli on the arrhythmia of acute coronary syndrome(ACS) and angiotensin Ⅱ(AngⅡ).Methods:Fifty-five cases with ACS were randomly divided into control group(27 cases) which were treated with conventional medication and treatment group(28 cases) which were treated with conventional medication added to wenxinkeli by oral.The arrhythmia and plasma AngⅡof two groups were observed.Results:The arrhythmia of the treatment group were less than that of the control group(P0.05).The plasma concentration of AngⅡ and N-terminal prohormone of brain natriuretic peptide of two groups had no significant difference at 2 weeks after treatment with wenxinkeli(P0.05).The mortality of two groups had no obviouse difference after 6 months(P0.05).Conclusions:Wenxinkeli can treat arrhythmia,prevent serious arrhythmia and no side-effects in the patients with ACS,which has no influence on plasma AngⅡafter 2 weeks.

About this research paper

What this paper is about

Objective:To observe the effects of wenxinkeli on the arrhythmia of acute coronary syndrome(ACS) and angiotensin Ⅱ(AngⅡ).Methods:Fifty-five cases with ACS were randomly divided into control group(27 cases) which were treated with conventional medication and treatment group(28 cases) which were treated with conventional medication added to wenxinkeli by oral.The arrhythmia and plasma AngⅡof two groups were observed.Results:The arrhythmia of the treatment group were less than that of the control group(P0.05).The plasma concentration of AngⅡ and N-terminal prohormone of brain natriuretic peptide of two groups had no significant difference at 2 weeks after treatment with wenxinkeli(P0.05).The mortality of two groups had no obviouse difference after 6 months(P0.05).Conclusions:Wenxinkeli can treat arrhythmia,prevent serious arrhythmia and no side-effects in the patients with ACS,which has no influence on plasma AngⅡafter 2 weeks.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To observe the effects of wenxinkeli on the arrhythmia of acute coronary syndrome(ACS) and angiotensin Ⅱ(AngⅡ).Methods:Fifty-five cases with ACS were randomly divided into control group(27 cases) which were treated with conventional medication and treatment group(28 cases) which were treated with conventional medication added to wenxinkeli by oral.The arrhythmia and plasma AngⅡof two groups were observed.Results:The arrhythmia of the treatment group were less than that of the control group(P0.05).The plasma concentration of AngⅡ and N-terminal prohormone of brain natriuretic peptide of two groups had no significant difference at 2 weeks after treatment with wenxinkeli(P0.05).The mortality of two groups had no obviouse difference after 6 months(P0.05).Conclusions:Wenxinkeli can treat arrhythmia,prevent serious arrhythmia and no side-effects in the patients with ACS,which has no influence on plasma AngⅡafter 2 weeks.

Key concepts: Medicine, Internal medicine, Acute coronary syndrome, Prohormone, Cardiology, Significant difference, Angiotensin II, Receptor

Related papers

Back to paper searchBrowse research topicsOriginal source
The effects of wenxinkeli on the arrhythmia of acute coronary syndrome and angiotensin II — Research Paper | ScholarLens